RaySearch Laboratories AB (publ) Interim Report January 1 - September 30, 2004

• Net sales totaled SEK 29.0m (24.9) between January and September 2004 • Net profit was SEK 11.3m (7.4) during the period • Earnings per share after tax reached SEK 1.08 (0.70) • Operating profit totaled SEK 12.9m (11.4) • Investments in research and development increased by 60 percent • New products based on the partnership with both Philips which Nucletron have been well received at significant industry meetings • First OM-Optimizer order received For more information, please contact: Johan Löf CEO, RaySearch Laboratories AB Phone: +46 (0)8-545 061 30 johan.lof@raysearchlabs.com

About Us

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading medical technology companies such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched via partners and RaySearch’s software is used by over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the company is listed in the Small Cap segment on Nasdaq Stockholm.


Documents & Links